PARMA international protocol: Pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/2/suppl_1/57/536835/2-suppl_1-57.pdf
Reference32 articles.
1. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma;Appelbaum;Blood,1978
2. Prolonged complete remission following high-dose chemotherapy of Burkitt’s lymphoma in relapse;Appelbaum;Cancer,1978
3. Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin’s malignant lymphoma with a very bad prognosis;Philip;Eur J Cancer Clin Oncol,1983
4. Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt’s lymphoma (30 courses in 28 patients: A 5 year experience);Philip;Eur J Cancer Clin Oncol,1986
5. The effects of high dose polychemotherapy with autologous bone marrow transplantation in 18 children with relapsed lymphoma;Hartmann;Eur J Cancer Clin Oncol,1982
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-CD19 Chimeric Antigen Receptor T Cell Therapy With Tisagenlecleucel for Secondary Central Nervous System Lymphoma: A Case Series;Cureus;2023-09-12
2. Outcome of CBV (Carmustine, Cyclophosphamide, Etoposide) Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma: A Retrospective Study from a Tertiary Cancer Center in South India;Indian Journal of Medical and Paediatric Oncology;2022-02-02
3. Outcomes of Diffuse Large B-Cell Non-Hodgkin’s Lymphoma After Gemcitabine-Based Second Salvage Chemotherapy: A Single-Center Study;Cureus;2021-11-18
4. Immunotherapy in the treatment of lymphoma;World Journal of Stem Cells;2021-06-26
5. Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar;Frontiers in Immunology;2021-01-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3